Intellia Therapeutics Inc
Ownership
Ownership Structure
Who owns Intellia Therapeutics Inc (NTLA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.8% of the shares are freely tradable; institutional investors hold 76.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Investment Management LLC | 12.04 | 16,875,684 | +16.3 | 06/30/2026 |
| BlackRock Inc | 11.00 | 15,409,023 | +26.8 | 06/30/2026 |
| State Street Corp | 6.59 | 9,234,987 | +33.4 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 5.23 | 7,332,401 | +17.8 | 06/30/2026 |
| D. E. Shaw & Co LP | 4.60 | 6,443,323 | +12.5 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.30 | 6,028,586 | +18.6 | 06/30/2026 |
| Two Sigma Investments LLC | 3.74 | 5,235,348 | +11.3 | 06/30/2026 |
| FMR Inc | 3.41 | 4,773,034 | +130.9 | 06/30/2026 |
| RA Capital Management, LLC | 3.23 | 4,526,926 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Innovation ETF | 7.14 | 10,002,700 | +1.7 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Leonard John M | President and CEO | 1,147,064 | 13,420,649 $ | Aug 21, 2026 | direct |
| Marantz Jing L. | EVP, Chief Medical Officer | 199,822 | 2,337,917 $ | Oct 26, 2026 | direct |
| Dube Michael P | VP, Chief Accounting Officer | 65,022 | 760,757 $ | Oct 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Marantz Jing L. | EVP, Chief Medical Officer | Other | 199,822 | 0.00 | – |
| Oct 2, 2026 | Dube Michael P | VP, Chief Accounting Officer | Sell | 1,864 | 12.43 | 23,170 |
| Aug 21, 2026 | Leonard John M | President and CEO | Sell | 2,785 | 13.00 | 36,205 |
| Aug 20, 2026 | Leonard John M | President and CEO | Sell | 19,890 | 12.60 | 250,614 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.